Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Neutralizing Antibody
94%
B Cell
89%
Epitope
84%
COVID-19
76%
Severe Acute Respiratory Syndrome Coronavirus 2
61%
Germ Cell
52%
Peptides
49%
Spike
41%
Receptor Binding
39%
Precursor
38%
Intravenous Immunoglobulin
35%
Neutralization
26%
Glycan
26%
SARS Coronavirus
25%
Monoclonal Antibody
25%
Epitope Mapping
24%
Inflammatory Bowel Disease
22%
Light Chain
19%
Antibody Response
19%
Crystal Structure
18%
Phage Display
18%
Binding Site
18%
Immune Response
17%
Virus
17%
B-Cell Receptor
15%
CD4
15%
Mycobacterium Tuberculosis
14%
Infectious Agent
12%
Somatic Mutation
12%
Immunogenicity
11%
Mycobacteria
11%
Monkeypox Virus
11%
Primary Immunodeficiency
11%
Tumor Necrosis Factor Alpha
11%
Interleukin-33
11%
Seroconversion
11%
Membrane Transport Protein
11%
Transgenic Mouse
11%
Monkeypox
11%
Tumor Necrosis Factor
11%
Programmed Death-Ligand 1
11%
Immunotherapy
11%
Tumor Cell
11%
Somatic Hypermutation
11%
Antibody Secreting Cell
11%
Plasmablast
11%
Immunoglobulin G
11%
Autoantibodies
11%
Glycoprotein
10%
Keyphrases
Epitope
71%
Broadly Neutralizing Antibodies
56%
HIV Antibodies
55%
COVID-19
47%
Neutralizing Antibodies
46%
B Cells
43%
Receptor-binding Domain
41%
Germ Cells
39%
Glycans
39%
Human Immunodeficiency Virus Type 1 (HIV-1)
36%
BNAbs
34%
Immunogen
33%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
33%
B Cell Response
32%
Knock-in Mouse Model
26%
Monoclonal Antibody
26%
Epitope Mapping
24%
HIV-1 Envelope Trimer
23%
Broadly Neutralizing
22%
COVID-19 mRNA Vaccine
22%
Severe COVID-19
22%
Tuberculosis
22%
Inflammatory Bowel Disease
22%
Response to COVID-19
22%
Antibody Response
21%
Viral
21%
Trimer
20%
Native-like
18%
Disease Severity
18%
Virus
18%
Spike Protein
17%
COVID-19 Patients
16%
ACE2 Binding
16%
3D Structure
16%
Immunization
16%
Germline Antibody
16%
PGT121
16%
CD4-binding Site
16%
Envelope Trimer
15%
Autoreactive
15%
SARS-CoV-2 Infection
14%
Structural Characterization
14%
Mild Infection
13%
Somatic mutation
13%
Antibody Titer
13%
Computational Prediction
13%
Antibody Targeting
13%
High Affinity
13%
Memory B-cell Response
13%
Sequential Immunization
13%